Up-front use of aromatase inhibitors as adjuvant therapy for breast cancer: the emperor has no clothes.
Seruga
Bostjan
B
Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Ontario, Canada.
Tannock
Ian F
IF
D047072:Aromatase Inhibitors / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy; D016019:Survival Analysis
D047072:Aromatase Inhibitors